124 related articles for article (PubMed ID: 4186148)
1. [Inorganic and organic phases of radioiodine metabolism in the thyroid in Basedow patients treated with synthetic thyroid antagonists].
Valentini F; Lodeserto A; Reschini E; Vivarelli S; Miedico D
Folia Endocrinol; 1968 Aug; 21(4):385-95. PubMed ID: 4186148
[No Abstract] [Full Text] [Related]
2. [The inhibition test of thyroid function with triiodothyronine in hyperthyroid patients under medical therapy: comparison of the values obtained from measures of "early" uptake and in the organic phase].
Valentini F; Reschini E; Lodeserto A; Vivarelli S; Miedico D
Folia Endocrinol; 1968 Aug; 21(4):396-403. PubMed ID: 4185869
[No Abstract] [Full Text] [Related]
3. Iodine distribution in thyroid tissue taken from hyperthyroid patients treated with Lugol's solution or carbimazole.
Etling N
Rev Eur Etud Clin Biol; 1971; 16(7):662-7. PubMed ID: 4107371
[No Abstract] [Full Text] [Related]
4. Treatment of toxic nodular and diffuse goitre with radioactive iodine. Late results and use of carbimazole.
Viherkoski M; Lamberg BA; Hernberg CA; Niemi E
Acta Endocrinol (Copenh); 1970 May; 64(1):159-70. PubMed ID: 4195421
[No Abstract] [Full Text] [Related]
5. [Combination of low doses of iodine 131 and synthetic antithyroid drugs in long-term care of Basedow's disease. Its value in the prevention of secondary hypothyroidism. (Apropos of 165 cases)].
Jaffiol C; Baldet L; Ghachem M; Robin M; Mirouze J
Sem Hop; 1973 Feb; 49(10):683-92. PubMed ID: 4122346
[No Abstract] [Full Text] [Related]
6. Thyroidal suppressibility after stopping long-term treatment of thyrotoxicosis with anti-thyroid drugs.
Alexander WD; Harden RM; McLarty D; Shimmins J
Metabolism; 1969 Jan; 18(1):58-62. PubMed ID: 4179400
[No Abstract] [Full Text] [Related]
7. The response in toxic diffuse goitre to a short course of antithyroid therapy.
Clark F; Hall R; Anderson J; Farmer FT
Clin Sci; 1970 Jul; 39(1):2P. PubMed ID: 4194428
[No Abstract] [Full Text] [Related]
8. Effect of TSH on the 24-hr 131-I uptake in Graves' disease.
Charkes ND
J Nucl Med; 1969 May; 10(5):246-8. PubMed ID: 4181519
[No Abstract] [Full Text] [Related]
9. Suppressibility of thyroid function during treatment with antithyroid drugs in Grave's disease.
Wils JA; Kloppenborg PW
J Clin Endocrinol Metab; 1970 Mar; 30(3):406-7. PubMed ID: 4189571
[No Abstract] [Full Text] [Related]
10. Prediction of the long-term results of antithyroid drug therapy for thyrotoxicosis.
Alexander WD; McLarty DG; Robertson J; Shimmins J; Brownlie BE; Harden RM; Patel AR
J Clin Endocrinol Metab; 1970 Apr; 30(4):540-3. PubMed ID: 4190916
[No Abstract] [Full Text] [Related]
11. [On the increase of urinary radioactivity after administration of tapazole in subjects pretreated with radioiodine. I. Behavior in hyperthyroidism and in simple sporadic goiter].
Minozzi M; Faggiano M; Nunziata V; Bianco A
Folia Endocrinol; 1966 Aug; 19(4):452-63. PubMed ID: 4170448
[No Abstract] [Full Text] [Related]
12. [Metabolism of organic iodine studied after administration of labeled iodide].
Busnardo B; Casson F
Acta Isot (Padova); 1966 Dec; 6(2):129-47. PubMed ID: 4171572
[No Abstract] [Full Text] [Related]
13. [Thyroid function and the state of the hypothalamus-hypophysis-thyroid in patients with diffuse toxic goiter after treatment].
Aliakparova ASh
Sov Med; 1973 Dec; 36(12):45-8. PubMed ID: 4130665
[No Abstract] [Full Text] [Related]
14. Plasma glycerol and glycerol turnover during treatment of hyperthyroidism.
Tibbling G; Cederquist E; Lundquist A
Clin Chim Acta; 1969 Aug; 25(2):189-98. PubMed ID: 4184576
[No Abstract] [Full Text] [Related]
15. Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies.
Pinchera A; Liberti P; Martino E; Fenzi GF; Grasso L; Rovis L; Baschieri L; Doria G
J Clin Endocrinol Metab; 1969 Feb; 29(2):231-8. PubMed ID: 4179303
[No Abstract] [Full Text] [Related]
16. [Criteria for recovery from diffuse toxic goiter].
Baranov VG; Nikolaenko NF
Klin Med (Mosk); 1970 Apr; 48(4):50-3. PubMed ID: 4193305
[No Abstract] [Full Text] [Related]
17. [Dynamics of PBI behavior in blood serum of patients with Graves-Basedow disease and toxic nodular goiter during treatment with methimetazole].
Jaruga-Dolińska E; Zembrzuska Z; Korman E
Endokrynol Pol; 1971; 22(6):535-43. PubMed ID: 4110630
[No Abstract] [Full Text] [Related]
18. [Use of Tc 99m-pertechnetate for the study inorganic iodine absorption by the thyroid gland under the effects of antithyroid preparations].
Kotliarov EV; Budkevich IuB
Med Radiol (Mosk); 1970 Jun; 15(6):55-8. PubMed ID: 4194224
[No Abstract] [Full Text] [Related]
19. New normal ranges for the radioiodine uptake study.
Bernard JD; McDonald RA; Nesmith JA
J Nucl Med; 1970 Jul; 11(7):449-51. PubMed ID: 4193901
[No Abstract] [Full Text] [Related]
20. [The treatment of hyperthyroid syndromes. I. Specific therapy. (Clinico-statistical contribution)].
Donati GS; Guagliano G; Scotti-Foglieni C; Cortinovis R; Pedroni G; Molteni F
Chir Ital; 1967 Dec; 19(6):957-1106. PubMed ID: 4180460
[No Abstract] [Full Text] [Related]
[Next] [New Search]
